Abstract: Preparation of optically-pure derivatives of 2-hydroxy-2-(3-hydroxyphenyl)-2-phenylacetic acid of general structure 2 was accomplished by enzymatic hydrolysis of the correspondent esters. A screening with commercial hydrolases using the methyl ester of 2-hydroxy-2-(3-hydroxyphenyl)-2-phenylacetic acid (1a) showed that crude pig liver esterase (PLE) was the only preparation with catalytic activity. Low enantioselectivity was observed with substrates 1a-d, whereas PLE-catalysed hydrolysis of 1e proceeded with good enantioselectivity (E = 28), after optimization. Enhancement of the enantioselectivity was obtained by chemical re-esterification of enantiomerically enriched 2e, followed by sequential enzymatic hydrolysis with PLE. The preparation of optically-pure (S)-2e was validated on multi-milligram scale.
Introduction
Enzymatic hydrolysis of chiral esters using carboxylesterases is an established method for obtaining kinetic and dynamic resolution [1] [2] [3] [4] [5] . A number of stereoselective carboxylesterases is nowadays available, and troublesome application such as the hydrolysis of spatially bulky substrates can be solved by screening and protein engineering [6] . Esters of carboxylic acids with sterically-demanding ↵-substitutions are not easily hydrolysed by most of the lipases, and protein engineering for making natural enzymes able to accept these substrates is still limited to relatively bulky carboxylic acids [7] . Enzymatic hydrolysis of carboxylic acid esters having an ↵-quaternary or ↵-tertiary centre is still a difficult task [8] ; in contrast to the broad spectrum of esters with bulky alcohol moieties accepted as substrates [9, 10] . Activation by electron-withdrawing (EW) hetero-atoms (e.g., O and N) or by EW-functional groups (e.g., -NO 2 , -CN, -CF 3 ) is often required to observe enzymatic hydrolytic activity [11] [12] [13] . ↵-,↵-Disubstituted malonate diesters are among the few ↵-,↵-,↵-trisubstituted carboxylic esters accepted by carboxylesterases; in particular, pig liver esterase (PLE) is particularly suited for catalyzing the enantioselective monohydrolysis of differently substituted malonate diesters [14] , including ester derivatives, such as dimethyl 3,3-dimethyl-2-methylenecyclohexane-1,1-dicarboxylate, a chiral building block used for the enantioselective total synthesis of ent-kauranoids [15] . 
Results

Screening of Biocatalysts and Substrates
The synthesis of esters 1a-e, used in this work, was realized as described in Scheme 1. Hydrolysis of 1a-b was firstly investigated using 20 commercial hydrolases and 15 enzymatic preparations from our laboratory [19] [20] [21] [22] [23] [24] ; only commercial PLE gave hydrolysis of 1a,b (Scheme 2) with conversions ranging between 50 and 100% after 24 hours (Table 1) .
Scheme 2. Enzymatic hydrolysis of esters 1a-b with pig liver esterase (PLE). 
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Scheme 2. Enzymatic hydrolysis of esters 1a-b with pig liver esterase (PLE). Scheme 2. Enzymatic hydrolysis of esters 1a-b with pig liver esterase (PLE). The reactions occurred with excellent rates, but low enantioselectivity, furnishing the S-acid with enantiomeric ratio (E) ranging between 8 and 10. Absolute configurations were assigned by comparison with enantiomerically pure sample previously synthesized [16] . Different (bulkier) alcohol moieties were introduced with the aim of increasing the enantioselectivity, therefore esters 1c,d were synthesized as shown before and used as substrates for the enzymatic hydrolysis with commercial PLE, but enantioselectivity remained quite low (E < 8 in both the cases).
As a strategy for improving enantioselectivity, we synthesized 1e, where a benzyloxy propylcarbamate was introduced as meta-substituent for boosting the structural diversity of the two aromatic groups (Scheme 3).
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In fact, the kinetic resolution of 1e occurred with higher enantioselectivity (E = 21, entry 1, Table  2 ) than what observed with 1a-d. Commercial PLE preparation is extracted from animal tissues and composed by 6 different isoenzymes, each one potentially leading to different stereoselectivity [14, 25] ; therefore, we also tested the six isoforms as single recombinant enzymes (commercially available and named ECS-PLE 01-06) for the hydrolysis of 1e (Table 2 , entries 2-7). Table 2 . Hydrolysis of 1e with PLE; conditions: [S] = 2.5 mM, [PLE] 7.5 mg/mL in 100 mM phosphate buffer at pH = 7.0 and DMSO (5%), 30 °C. The highest enantioselectivity was observed with the recombinant isoform ECS-PLE06 (entry 7, Table 3 ), comparable with the one obtained with crude PLE, which, in turn, showed higher specific activity.
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In fact, the kinetic resolution of 1e occurred with higher enantioselectivity (E = 21, entry 1, Table 2 ) than what observed with 1a-d. Commercial PLE preparation is extracted from animal tissues and composed by 6 different isoenzymes, each one potentially leading to different stereoselectivity [14, 25] ; therefore, we also tested the six isoforms as single recombinant enzymes (commercially available and named ECS-PLE 01-06) for the hydrolysis of 1e (Table 2 , entries 2-7). The highest enantioselectivity was observed with the recombinant isoform ECS-PLE06 (entry 7, Table 3 ), comparable with the one obtained with crude PLE, which, in turn, showed higher specific activity.
Optimization
Crude PLE was therefore used for further optimization, carried out using an experimental design (Multisimplex v2.0 (Multisimplex AB, Karlskrona, Sweden), previously used for optimizing the conditions of different biotransformations [26] . The control variables were substrate and enzyme concentration, pH, co-solvent (DMSO) concentration, and temperature. Productivity at 24 h and , where the ratio between substrate and enzyme was reduced, the highest enantioselectivity (E = 28) was obtained, but reaction rate slowed down. Under these conditions, enzymatic hydrolysis gave 2e with an ee of 90% after 24 h, in correspondence of 30% conversion.
As previously reported, the addition of co-solvents, which alter the solubility of the substrate, may affect the enantioselectivity and the reaction rate of reactions catalyzed by crude PLE [14, 27] . Consequently, we investigated the activity and the enantioselectivity on the hydrolysis of 1e with crude PLE carried out under optimized conditions in the presence of the solvents listed in Table 3 . Protic water-soluble co-solvents (EtOH and iPrOH, entries 2 and 3, Table 3 ) suppressed enzymatic activity, whereas, DMSO (firstly chosen as co-solvent) was the only polar co-solvent with beneficial effects (entry 4, Table 3 ). Detected activity and enantioselectivity in the presence of highly hydrophobic solvents (n-heptane and isooctane, entries 9 and 10, Table 3 ) were lower than the ones obtained in water containing 8% DMSO. Reactions performed in the presence of different concentrations of hydrophobic solvents (10, 30, 50% v/v) did not show any significant differences.
Another way to influence the overall reactivity of organic substrates in aqueous enzymatic reactions involves the use of cyclodextrins (CDX) [28] . CDX can modify the solubility of organic compounds in water, while establishing diastereoisomeric interactions with chiral substrates; for these reasons, different CDX were tested as additive in the enzymatic hydrolysis of 1e (Table 4) . Cyclodextrins generally improved the reaction rates, with -CDX showing the highest acceleration (entry 1, Table 4 ). The screening shown in Table 5 was carried out using a slight excess of CDX over the substrate, so we decided to explore the effect of different stoichiometric ratios between -CDX and substrate ( Table 5 ), observing that no significant improvements were obtained above 1.25 ratio -CDX/substrate. 
Preparative Biotransformation
A preparative biotransformation was thus performed starting from 150 mg of 1e (Figure 2 ) using the best reaction conditions (entry 2, Table 5 ).
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A preparative biotransformation was thus performed starting from 150 mg of 1e (Figure 2 ) using the best reaction conditions (entry 2, Table 5 ). The reaction was stopped in correspondence of 54% conversion (after 40 hours), allowing for the recovery and purification of 2e (67 mg) with an ee of 80%. This batch of optically-enriched 2e was chemically methylated to give optically enriched 1e, which was subsequently hydrolysed with PLE, furnishing 50 mg of optically pure (S)-2e. The overall results of this sequential kinetic resolution are given in Scheme 4. 
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Sterically demanding 2,2-diaryl-2-hydroxy carboxylic acids are valuable chiral building blocks for the synthesis of antimuscarinic agents [9] . Two major problems were encountered in the enzymatic kinetic resolution of these bulky substrates. Firstly, esters having α-quaternary or α-tertiary center show severe steric hindrance that hampers the approach to the active site; in fact, among the different enzymes tested, PLE was the only enzyme active on these substrates. Besides, esters of 2-hydroxy-2-(3-hydroxyphenyl)-2-phenylacetate (the ones considered here as key precursors for antimuscarinic agents preparation) display poor stereo-discrimination due to the The reaction was stopped in correspondence of 54% conversion (after 40 h), allowing for the recovery and purification of 2e (67 mg) with an ee of 80%. This batch of optically-enriched 2e was chemically methylated to give optically enriched 1e, which was subsequently hydrolysed with PLE, furnishing 50 mg of optically pure (S)-2e. The overall results of this sequential kinetic resolution are given in Scheme 4.
Preparative Biotransformation
Discussion
Sterically demanding 2,2-diaryl-2-hydroxy carboxylic acids are valuable chiral building blocks for the synthesis of antimuscarinic agents [9] . Two major problems were encountered in the enzymatic kinetic resolution of these bulky substrates. Firstly, esters having α-quaternary or α-tertiary center show severe steric hindrance that hampers the approach to the active site; in fact, among the different enzymes tested, PLE was the only enzyme active on these substrates. Besides, esters of 2-hydroxy-2-(3-hydroxyphenyl)-2-phenylacetate (the ones considered here as key precursors for antimuscarinic agents preparation) display poor stereo-discrimination due to the Scheme 4. Preparation of optically pure 2e after sequential enzymatic hydrolysis of 1e with PLE.
Sterically demanding 2,2-diaryl-2-hydroxy carboxylic acids are valuable chiral building blocks for the synthesis of antimuscarinic agents [9] . Two major problems were encountered in the enzymatic kinetic resolution of these bulky substrates. Firstly, esters having ↵-quaternary or ↵-tertiary center show severe steric hindrance that hampers the approach to the active site; in fact, among the different enzymes tested, PLE was the only enzyme active on these substrates. Besides, esters of 2-hydroxy-2-(3-hydroxyphenyl)-2-phenylacetate (the ones considered here as key precursors for antimuscarinic agents preparation) display poor stereo-discrimination due to the presence of two aromatic groups, directly bound to the stereocenter, which differ only for the presence of a meta-substituent on one of the two aromatic rings. Derivative 1e, which bears a benzyloxy propylcarbamate substituent in meta-position, gives sufficient stereo-differentiation for achieving moderate-to-good enantioselectivity (E = 28). Moreover, the biotransformation was optimized by choosing suited co-solvents (DMSO) and additives ( -CDX).
The preparative significance of this method was established by the expedient preparation of optically pure (S)-2e on multi-milligram scale, using a sequential kinetic resolution approach.
Materials and Methods
All chemicals were from Sigma-Aldrich (Milano, Italy) and/or VWR International (Milano, Italy) and used without further purification unless otherwise stated. Pig liver esterase was purchased from Sigma-Aldrich (Milano, Italy). PLE isoforms were from Enzymicals (Greifswald, Germany).
-Cyclodextrins were provided by Wacker-Chemie GmbH (Munchen, Germany). Anhydrous solvents were purchased from Aldrich and used as received. "Brine" refers to a saturated aqueous solution of NaCl. Unless otherwise specified, solutions of common inorganic salts used in workups are aqueous solutions. Optically pure/enriched compounds, used as HPLC standards, were synthesised as previously described [17] .
Analyticals
HPLC analyses were performed with a Jasco PU-980 pump equipped with a UV-VIS detector Jasco UV-975 (Easton, MD, USA). The NMR of 1 H and 13 C spectra were recorded in DMSO using Bruker 600 MHz or 400 MHz spectrometer (Karlsruhe, Germany), equipped with a self-shielded z-gradient coil 5 mm 1 H/ n X broad band probehead for reverse detection, deuterium digital lock channel unit, quadrature digital detection unit with transmitter offset frequency shift. Chemical shifts are reported as downfield in parts per million (ppm) and referenced to tetramethylsilane (TMS) as the internal standard in the 1 H measurements. Coupling constants (J values) are given in hertz (Hz) and multiplicities are reported using the following abbreviation (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad, nd = not determined). The pulse programs were taken from the Varian and Bruker software libraries. The HRMS spectra were recorded on an Agilent instrument (Santa Clara, CA, USA) using the Time-of-Flight Mass Spectrometry (TOF MS) technique. Specific rotation of compounds was measured with a Polarimeter Perkin Elmer (model 241 or 341, Waltham, USA) at sodium D-line (589 nm), 25 C, 1 dm path length. Reactions were monitored by TLC using 0.25 mm Merck silica gel plates (60 F254, Darmstadt, Germany). For chiral analysis the samples were analysed using a chiral column for the separation of the enantiomers. HPLC analyses were carried out on a Kromasil 5-Amycoat column 4.6 ⇥ 250 mm (CPS Analitica, Milan, Italy), 5 µm; mobile phase: n-hexane:isopropanol:TFA 8:2:0.1%, flow rate 1 mL/min, = 220 nm. Optically pure/enriched compounds were chemically synthesised as chiral HPLC standards. Column chromatography was performed on Merck silica gel 60 (0.063-0.2 mm).
Procedure for the Synthesis of methyl 2-(4-(benzyloxy)phenyl)-2-hydroxy-2-phenylacetate (1a)
To a solution of methyl 2-oxo-2-phenylacetate (12.83 mL, 91 mmol) in THF (Volume: 350 mL), (4-(benzyloxy)phenyl)magnesium bromide (100 mL, 100 mmol) was added dropwise at 0 C over 30 min and stirred overnight at RT. Reaction was partitioned between AcOEt and saturated NaCl, organic phase dried over Na 2 SO 4 Figures S2 and S3, respectively) .
Procedure for the Synthesis of methyl 2-hydroxy-2-(3-hydroxyphenyl)-2-phenylacetate (1b)
Methyl 2- (3-(benzyloxy)phenyl)-2-hydroxy-2-phenylacetate (1a) (200 mg, 0.574 mmol),  1-methylcyclohexa-1,4-diene (129 µl, 1.148 mmol) and Pd/C 10% wet (60 mg, 0.028 mmol) were refluxed in EtOH (2870 µl) in a closed vessel at 80 C for 8 h, then the mixture filtered on PTFE membrane and evaporated under reduced pressure. The resulting oil was recrystallized in a mixture of cyclohexane/iPr 2 O to give methyl 2-hydroxy-2-(3-hydroxyphenyl)-2-phenylacetate (130 mg, 0.503 mmol, 88% yield) as a white powder. 1 Methyl 2-(3-(benzyloxy)phenyl)-2-hydroxy-2-phenylacetate (1a) (5 g, 14.35 mmol) and LiOH (1.031 g, 43.1 mmol) were dissolved in THF (Volume: 15 mL)/Water (Volume: 15.00 mL) and stirred for 2 h at RT. Reaction was quenched by the addition on 1M HCl and extracted with AcOEt, the organic phase was washed with aqueous NaCl and dried over Na 2 SO 4 before being evaporated under reduced pressure. The desired product 2-(3-(benzyloxy)phenyl)-2-hydroxy-2-phenylacetic acid (2a) (5.1 g, 15.25 mmol, 106 % yield) was obtained as a yellowish foam, not isolated and used as such for the following step. 2-(3-(Benzyloxy)phenyl)-2-hydroxy-2-phenylacetic acid (2a) (2.5 g, 7.48 mmol) and CDI (2.425 g, 14.95 mmol) were reacted for 5 min in DCM (Volume: 8 mL) prior the addition of 2-(dimethylamino)ethanol (2.257 mL, 22.43 mmol). Reaction was stirred for 4 h at 60 C, then partitioned between AcOEt and sat NaHCO 3 aq, washed twice with water, dried over Na 2 SO 4 and evaporated under reduced pressure. The crude was chromatographed on silica gel by gradient elution from 100 % AcOEt to AcOEt/MeOH (7N NH3) 90/10 in 12 CV to give 2-(dimethylamino)ethyl 2-(3-(benzyloxy)phenyl)-2-hydroxy-2-phenylacetate (1c) (1.02 g, 2.52 mmol, 33.6 % yield) as a yellowish oil. 1 2-(3-(benzyloxy)phenyl)-2-hydroxy-2-phenylacetic acid (2a) (2.5 g, 7.48 mmol) and CDI (2.425 g, 14.95 mmol) were reacted for 5 min in DCM (Volume: 15 mL) prior the addition of (1-benzylpiperidin-4-yl)methanol (2.3 g, 11.20 mmol). Reaction was stirred for 3 h at 60 C, then DMF was added and the mixture was stirred at 80 C for 4 h. The mixture was partitioned between AcOEt and an aqueous solution of NaHCO 3 , washed twice with water, dried over Na 2 SO 4 and evaporated under reduced pressure. The crude was chromatographed first on silica gel (gradient elution from 100 % AcOEt to AcOEt/MeOH (7N NH 3 ) 90/10 in 10 CV), then by flash chromatography on a reverse Methyl 2-hydroxy-2-(3-hydroxyphenyl)-2-phenylacetate (2b) (570 mg, 2.207 mmol) and 3-(((benzyloxy)carbonyl)amino)propyl methanesulfonate (761 mg, 2.65 mmol) were dissolved in DMF (6 mL), followed by the addition of CsCO 3 (1079 mg, 3.31 mmol). The reaction solution was stirred at room temperature overnight. The reaction mixture was quenched adding water then extracted with EtOAc. The organic phase was dried over Na 2 SO 4 , filtered and evaporated under reduced pressure. The crude was purified by flash chromatography (25 g silica, from 20 to 50 % EtOAc in heptane) to obtain the desired product methyl 2-(3-(3-(((benzyloxy)carbonyl)amino)propoxy)phenyl)-2-hydroxy-2-phenylacetate (1e) (670 mg, 1.491 mmol, 67.5 % yield) as a colourless oil. 1 
Enantiomeric Excess Determination
The enantiomeric excess (ee %) was determined by HPLC with a Kromasil 5-Amycoat column 4.6 ⇥ 250 mm, 5 µm, mobile phase: n-hexane:isopropanol: 
General Procedure for Biotransformations
Screening and optimization were carried out by performing reactions in 5 mL screw-capped test tubes with a reaction volume of 2 mL. Preparative biotransformations were carried out at 25 and 150 mL scale. Substrates (2.5-10 mM) were dissolved in DMSO (final concentration 5%) and added to phosphate buffer (100 mM, pH = 7). The reactions were started by the addition of the enzyme. The mixture was then kept at fixed temperature under magnetic stirring. Samples of the biotransformation mixture were withdrawn, diluted with an equal volume of water, acidified with 1 N HCl and extracted with eight volumes of EtOAc. The organic extract was then concentrated and analysed by HPLC.
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